ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 106

Patient Reported Outcomes Following Upper Extremity Arthroplasties in RA -a Report from the Swedish National Register of Rheuma Surgery (RAKIR)

Ann Bremander1,2, Sofia Forsberg3, Emelie Gull3 and Anna Nilsdotter3, 1Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden, 2Spenshult Research and Development Center, Halmstad, Sweden, 3Department of Research and Education, Halmstad Central Hospital, Halmstad, Sweden

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Arthroplasty and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research

Session Type: Abstract Submissions (ACR)

Background/Purpose: RAKIR, the Swedish National Register of Rheuma Surgery was created to follow joint surgery in patients with RA (rheumatoid arthritis).  The aim of this study was to analyze PROMs (patient reported outcome measures) from RAKIR concerning HRQoL (health related quality of life), pain and function in RA patients admitted for arthroplasty in the upper extremity. A secondary aim was to study expectations and satisfaction related with these procedures.

Methods: 106 (87 women, age mean 63, SD 13 years) patients with RA admitted for arthroplasty in the upper extremity, followed in RAKIR, were included (2007-2011). All patients answered the questionnaires SF-36, HAQ and QDASH preoperatively, 6 months postoperatively and at a 2-6 year follow-up (2013). Questions concerning expectations and satisfaction were asked at the same time.

Results: RA patients operated on with arthroplasty in the upper extremity (shoulder n=36, elbow n=20, wrist n=21 and MCP n=29) showed a significant improvement in HRQoL, pain and function 6 months after surgery (p ≤ 0.05, n=61). The improvement remained 2-6 years later (n=50). The patients’ expectations concerning pain relief was fulfilled, the expectations concerning improvement in ADL and function was surprisingly low but in an even greater extent fulfilled.

Conclusion: Long term follow-up with PROMs showed that patients with RA, in need of arthroplasty in the upper extremity, are satisfied, experience pain relief as well as improved function and HRQoL as long as 2-6 years after surgery. However, the response rate in a register is dependent on the patients´ benignity and may influence the results.


Disclosure:

A. Bremander,
None;

S. Forsberg,
None;

E. Gull,
None;

A. Nilsdotter,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-outcomes-following-upper-extremity-arthroplasties-in-ra-a-report-from-the-swedish-national-register-of-rheuma-surgery-rakir/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology